Duncker Streett & Co’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4K Hold
335
﹤0.01% 381
2026
Q1
$23.8K Hold
335
﹤0.01% 380
2025
Q4
$27.5K Hold
335
﹤0.01% 369
2025
Q3
$25.2K Sell
335
-166
-33% -$12.4K ﹤0.01% 371
2025
Q2
$37.1K Hold
501
0.01% 342
2025
Q1
$40.4K Sell
501
-4
-0.8% -$344 0.01% 325
2024
Q4
$39.5K Sell
505
-72
-12% -$6.12K 0.01% 336
2024
Q3
$54.2K Hold
577
0.01% 320
2024
Q2
$45K Hold
577
0.01% 328
2024
Q1
$52.5K Hold
577
0.01% 316
2023
Q4
$44.6K Hold
577
0.01% 320
2023
Q3
$39.3K Hold
577
0.01% 321
2023
Q2
$46.9K Sell
577
-14
-2% -$1.12K 0.01% 307
2023
Q1
$48.5K Buy
+591
New +$42.2K 0.01% 299

Other funds holding GEHC

Duncker Streett & Co's GEHC Position: Q2 2026 in Review

Duncker Streett & Co held its GE HealthCare (GEHC) position steady in Q2 2026 at 335 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #381.

Duncker Streett & Co first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $54.2K in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Duncker Streett & Co held 335 shares of GE HealthCare worth $21.4K as of Q2 2026.
  • Duncker Streett & Co left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up ﹤0.01% of Duncker Streett & Co's portfolio in Q2 2026, its #381 holding.
  • Duncker Streett & Co first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Duncker Streett & Co's GE HealthCare position peaked at $54.2K in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Duncker Streett & Co's 13F filing for Q2 2026, filed 28 Jul 2026.